Skip to main content
Premium Trial:

Request an Annual Quote

For-Profit, Nonprofit

Biotechnology executive Una Ryan believes everyone has the right to healthcare, says Technology Review's Emily Singer. As head of the nonprofit foundation Diagnostics for All, Ryan's goal is to provide access to healthcare and diagnostics in poor countries. To that end, her foundation is developing paper diagnostics — "cheap, portable, easy-to-manufacture tests that can be used in environments with few resources and little infrastructure," Singer says. Beyond a new kind of diagnostic, Ryan is also developing a new kind of business model. Although Diagnostics for All has received grants and charitable funding, Ryan is aware that these forms of funding are may not be adequate over the long term, Singer says. Hence, Diagnostics for All created its for-profit subsidiary, Paper Diagnostics, which will partner with companies to develop and market the tests for use in developed countries and reinvest its sales proceeds into the nonprofit, Singer adds.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.